相关实验视频
Updated: Jun 4, 2025

06:03
Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis
Published on: July 12, 2011
17.1K
在静脉血栓形成中,蛋白二硫化异构酶ERp18的新型作用
Chao He1, Aizhen Yang2, Yuxin Zhang3
1Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, Cyrus Tang Medical Institute, Soochow University, Suzhou, 215123, China.
Thrombosis journal
|December 19, 2024
概括
蛋白质二硫化异构酶家族成员ERp18促进静脉血栓形成. 它的酶活性和调节威尔布兰德因子的释放是这一过程的关键.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 血栓形成研究研究
背景情况:
- 之前的研究表明,蛋白质二硫化异合酶 (PDI) 家族成员与动脉血栓形成有关.
- 在静脉血栓形成中,PDI家族成员的作用在很大程度上仍未被探索.
研究的目的:
- 调查PDI家族成员对静脉血栓形成的贡献.
- 确定ERp18在静脉血栓形成中的特定作用.
主要方法:
- 产生了基因修饰的小鼠模型,缺少各种PDI家族成员.
- 评估静脉血栓使用下腔静脉 (IVC) 狭窄模型.
- 评估了复合人类ERp18 (rhERp18) 的酶活性及其对血栓形成和·维勒布兰德因子 (vWF) 水平的影响.
主要成果:
- 缺少大多数PDI家族成员的小鼠没有表现出改变的静脉血栓症表型.
- 缺乏ERp18的小鼠表现出明显减少的静脉血栓形成.
- ERp18的促血栓功能取决于其酶活性,而ERp18缺乏导致血栓部位的vWF水平降低.
结论:
- ERp18显著增强了静脉血栓的发展.
- ERp18的酶活性及其对vWF释放的调节对于其在静脉血栓形成中的作用至关重要.
相关概念视频
Protein Modifications in the RER
5.0K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.0K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K

